Amal Holdings: Diversification Worked, but 2026 Still Depends on the Home-Care Tender and Cash Discipline
Amal ended 2025 with 13% revenue growth, a sharp step-up in special-needs services, and stronger operating cash flow. But more than half of revenue still sits on National Insurance, and the aggressive dividend policy leaves 2026 as a proof year rather than a comfort year.
Getting To Know The Company
At first glance Amal Holdings looks like a simple growth story in health and welfare services. That is only part of the picture. By 2025 the group was no longer just a home-care operator. It was running four real operating engines: home care, nursing homes, mental health, and services for special-needs populations. Revenue rose to ILS 2.204 billion, headcount reached 30,248, and the group operated through 37 home-care branches and 14 nursing homes. This is not a tiny company priced on a hope story. At the April 9, 2026 closing price of ILS 17.20 per share, equity value was roughly ILS 2.4 billion. The market is judging earnings quality, capital allocation, and regulatory resilience.
What is working now is diversification. Special-needs services, accelerated by the August 2024 acquisition of ADNM, Neve Ram, and Neve Ram’s special-education school, contributed ILS 408.8 million of revenue and ILS 31.5 million of operating profit in 2025. Mental health remained the group’s highest-margin engine, with a 20.7% operating margin. Amal is no longer just a contractor selling care hours to the National Insurance Institute.
But that is also where the superficial read goes wrong. The core engine is still home care. That segment generated ILS 1.342 billion of revenue and ILS 106.5 million of operating profit, about 61% of group revenue and about 55% of group operating profit. Group-wide, 53% of revenue still came from National Insurance. So even after a strong diversification year, the big 2026 question is not whether ADNM was a good acquisition. It is whether Amal can get through the new home-care tender without a material hit to the economics of its legacy core.
The second active bottleneck is cash, not in the sense of covenant stress but in the sense of discipline. Operating cash flow rose to ILS 222.8 million, yet the company paid ILS 145 million of dividends, more than the year’s net profit of ILS 133.6 million. It also carried reported CAPEX, lease principal, and cash interest. That makes 2025 look less like a balance-sheet distress story and more like a year in which capital allocation is running ahead of the remaining regulatory uncertainty.
Four things matter upfront:
- Diversification improved in the numbers, not just in the narrative. National Insurance fell to 53% of revenue from 57% in 2024, and special needs became a real second profit engine.
- Home care still drives the story. As long as the new National Insurance tender remains unresolved, the thesis is still exposed to one regulatory layer.
- Covenants are not the immediate problem. The more relevant constraint is how much room remains after all the real cash uses.
- 2026 looks like a proof year. Amal has to show that the new mix translates not only into revenue, but into durable profit and real cash flexibility.
| Engine | 2025 Revenue | Share of Revenue | 2025 Operating Profit | Why It Matters |
|---|---|---|---|---|
| Home care | ILS 1,342.2m | 60.9% | ILS 106.5m | The core engine, and still the key regulatory risk |
| Special needs | ILS 408.8m | 18.5% | ILS 31.5m | The second growth engine, still in integration-and-proof mode |
| Nursing homes | ILS 265.4m | 12.0% | ILS 16.8m | A relatively stable base, but not the main profit driver |
| Mental health | ILS 177.7m | 8.1% | ILS 36.8m | The highest-margin engine, now facing wage pressure |
| Other | ILS 10.1m | 0.5% | ILS 3.6m | Small contribution, mainly from assets and ancillary services |
Events And Triggers
First trigger: 2025 is the first year in which ADNM shows up as a full operating engine rather than a partial-period add-on. Out of roughly ILS 260 million of group revenue growth, about ILS 189 million came from the special-needs segment. Of that, about ILS 143 million was linked to the fuller contribution of ADNM, while another roughly ILS 46 million came from organic expansion, mainly additional schools, communication-kindergarten services, and a hostel for people with disabilities. That matters because the group is trying to build breadth, not just add volume to an existing lane. It is also not an isolated move: over the last three years the group completed six acquisitions across its operating lanes, with combined annual turnover of roughly ILS 400 million at the time of acquisition.
Second trigger: the new National Insurance tender is still unresolved. The group first received the new tender documents in June 2024, went through a long round of clarifications and legal challenges, and in late October 2025 the existing arrangement was extended through December 31, 2026, or until the new process is completed, whichever comes first. That removes an immediate cliff. But the company also states clearly that the new tender includes material changes in tariffs and tariff structure, and that leaving those flaws uncorrected could hurt the home-care segment’s results. That is the heart of the story because 53% of group revenue still sits with the NII.
Third trigger: the stock-market listing created a small but real distortion in the 2025 read, especially in the fourth quarter. Other expenses of ILS 6.1 million, mostly one-off listing-related costs, do not change the annual thesis, but they do muddy the clean read of quarterly profitability.
Fourth trigger: February 2026 brought a partial board refresh, with approval for three external directors, renewed appointments for Lilach Asher-Topilsky, Yishai Davidi, and Dalia Korkin, plus the appointment of Yodfat Harel Buchris. In parallel, Shelly Sorek and Gavri Bargil left the board. This is not a valuation event by itself, but it does complete part of the governance framework expected from a company that only listed in November 2025.
Efficiency, Profitability, And Competition
Where The Profit Really Comes From
The most interesting part of 2025 is not just growth. It is the shift in profit buckets. Home care still produced the largest share, ILS 106.5 million, but it is no longer alone. Mental health contributed ILS 36.8 million of operating profit on ILS 177.7 million of revenue, a 20.7% margin and by far the highest in the group. Special needs delivered ILS 31.5 million of operating profit on ILS 408.8 million of revenue. Nursing homes added ILS 16.8 million. In practical terms, the new engine is already real, but not yet large enough for the market to ignore whatever happens in home care.
The segments differ in the quality of their growth. Mental health still carries premium margins, but the fourth quarter showed pressure, with segment profit down by roughly ILS 3 million, mainly because of extraordinary salary costs related to 2025 as a whole and newly added activities that had not yet generated full revenue. That is an important signal. Even a demand backdrop that is structurally supportive does not automatically become profit if labor costs move first.
In special needs, the quality of growth looks cleaner than a skeptical first read might suggest. Revenue almost doubled to ILS 408.8 million while the segment held a 7.7% operating margin, broadly unchanged from 2024. That tells you the acquisition expanded the business without wiping out profitability. But this is still not a premium-margin engine. To earn a higher-quality multiple, Amal still needs to show that new schools, hostels, and service lines can scale without eroding those margins.
What The Fourth Quarter Is Really Saying
The most revealing fourth-quarter data point sits in home care. Segment revenue rose by about ILS 10 million, but the move was not driven purely by volume. The company says roughly ILS 15 million came from tariff updates paid by National Insurance, while sold hours declined by about ILS 5 million. In other words, the quarter leaned more on supportive regulation than on clean activity growth. That is not inherently negative, but it is not the same thing as underlying demand acceleration.
Nursing homes show a similar pattern. Fourth-quarter revenue increased by ILS 3.7 million, mainly because of Health Ministry tariff increases, yet segment profit still fell by about ILS 0.8 million due to changes in patient mix and input mix. Again, higher revenue did not convert one-for-one into higher earnings. This is a regulated business with some support, but it remains sensitive to operational mix and cost intensity.
Cash Flow, Debt, And Capital Structure
Cash Flow, The Business Generates Cash But The Payout Consumes Most Of It
On the operating line, Amal looks solid. Cash from operations rose to ILS 222.8 million from ILS 189.7 million in 2024. That was supported by higher profit, movements in accruals, and stronger EBITDA at ILS 258.1 million. The business does generate cash.
But this is where framing matters. Because the core issue here is financing flexibility rather than recurring earning power in isolation, the right lens is all-in cash flexibility, meaning what remains after the period’s real cash uses. Under that lens, ILS 222.8 million of operating cash flow met reported CAPEX of ILS 28.5 million, dividends of ILS 145 million, lease principal of ILS 35.5 million, and cash interest of ILS 25.4 million. After CAPEX, dividends, and lease principal, only about ILS 13.8 million remained. Once cash interest is included, the picture turns slightly negative even before bank debt rollovers.
That is the point a surface-level read can miss. The business itself is not weak. But the dividend policy makes the cash cushion much tighter than the operating cash-flow line alone suggests. Year-end cash actually fell to ILS 18.6 million from ILS 20.5 million despite stronger operating cash generation. That does not imply immediate stress, but it does mean the company is distributing capital ahead of fully removing its regulatory uncertainty.
Debt, Less On-Call Credit And More Long-Term Funding
The good news is that the debt structure looks cleaner than a year ago. Negative working capital improved to minus ILS 103.9 million from minus ILS 177.5 million, and the company explicitly ties that improvement to shifting facilities from short term to long term. Short-term loans fell from ILS 104.2 million to ILS 9.2 million, while non-current bank debt rose from ILS 93.3 million to ILS 190.7 million. Amal bought itself time.
The covenant picture is also comfortable. At the parent-company level, the ratio of net financial debt to EBITDA was reported in a range of 0.23 to 0.96 against a ceiling of 5. At Amal VeMaavar, the range was 0.69 to 1.20 against the same ceiling. This is not a service company flirting with a covenant breach. The issue is not access to credit. The issue is what management chooses to do with that credit.
The business is, however, more rate-sensitive than before. The company states that a 1% change in interest rates would affect profit and equity by about ILS 1.746 million, versus ILS 0.869 million in 2024. That is not existential, but it is a reminder that the move to longer-term debt bought timing flexibility at the cost of greater sensitivity to the rate environment.
Forward View
2026 is a proof year, not a breakout year. What Amal needs to prove over the next two to four quarters is not the existence of diversification. It needs to prove the quality of that diversification.
The Home-Care Test
The first test is the National Insurance tender. The extension through the end of 2026 removes an immediate cliff, but by February 2026 the company had already received another file of clarifications and appendices, and it was still reviewing the implications. If Amal enters the winner list without a material hit to segment economics, a meaningful part of the regulatory discount should begin to narrow. If not, the other engines will have to work much harder just to offset the damage.
The ADNM Test
The second test is whether special needs becomes more than a revenue expansion story. Right now the numbers support the view that the acquisition created a legitimate second engine. But 2026 still needs to show that this engine produces not only scale, but steady profitability and cash. That matters because the company is continuing to grow through new schools, hostels, and service lines, which means the expansion requires execution, not just passive consolidation.
The Mental-Health Test
The third test is mental health. It remains a high-quality profit bucket, but the fourth quarter showed how salary agreements and newly added activities can load cost into the model before revenue catches up. If 2026 shows margin stability here, the market will be more willing to believe that higher demand actually converts into earnings rather than just more activity.
The Capital-Allocation Test
The fourth test is the quietest one, but maybe the most important. The company already paid a 2025 dividend that exceeded the year’s net profit. That is legal, and it does not threaten covenant compliance, but it does raise the bar for 2026. If Amal keeps distributing at this pace without stronger proof from the new engines and without clear tender resolution, investors will increasingly ask whether the company is pulling forward cash faster than its uncertainty is falling.
Risks
- Regulation and customer concentration: 53% of revenue comes from National Insurance, and a large additional share comes from government ministries and public bodies. The business mix is broader, but the funding mix is still overwhelmingly public.
- Wage inflation and staffing pressure: minimum-wage hikes, collective wage agreements for social workers, and staffing shortages, especially in mental health, continue to pressure margins before all tariff updates fully flow through.
- Aggressive capital allocation: a ILS 145 million dividend alongside year-end cash of ILS 18.6 million is not a balance-sheet crisis signal, but it does narrow the margin for error.
- Interest-rate exposure: debt has moved from short-term relief into a longer structure, but it remains largely based on prime plus spread, so rate moves still hit earnings directly.
Conclusions
Amal exits 2025 as a broader, more diversified, and operationally more impressive company than it was a year earlier. That is the positive part. The less clean part is that the legacy engine is still too large for the market to ignore, and the capital-distribution pace is faster than the pace of uncertainty removal.
Current thesis: Amal’s diversification is now real, but 2026 will still be judged mainly on whether home-care economics hold and whether cash discipline improves.
What changed: special needs no longer looks like a side add-on but like a real second growth engine, and National Insurance concentration has come down, though not enough to eliminate tender dependence.
Counter-thesis: if the new home-care tender damages segment economics, the improvement in ADNM and mental health will not be enough to protect the quality of group earnings.
What could change the market read in the short to medium term: a final tender structure, the first quarters without one-off listing expenses, and proof that special-needs and mental-health growth also converts into cash.
Why this matters: Amal can become a broader social-services platform with multiple profit engines, but to earn that identity it still has to show that the new mix is both profitable and financeable.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 4.0 / 5 | Scale, nationwide reach, a wide labor platform, and high system dependence on large service providers |
| Overall risk level | 3.4 / 5 | Regulation, wage pressure, and aggressive distributions weigh even if covenants remain comfortable |
| Value-chain resilience | Medium-high | No major supplier dependence, but deep reliance on public funding and labor availability |
| Strategic clarity | High | Management is explicit about expanding the four operating lanes through organic growth and acquisitions |
| Short-interest stance | 0.03% short float, SIR 0.36 | Below the sector averages of 0.10% and 0.652, so short sellers are not signaling a strong bearish read today |
If Amal gets through the tender without a material economic hit, stabilizes mental-health margins, and handles distributions more conservatively, the read on 2025 should improve in hindsight. If one of those three breaks, the market will likely fall back to viewing it mainly as a large home-care operator with supporting side engines rather than a genuinely diversified group.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
ADNM has already turned special needs into Amal’s second operating engine in scale and contribution, but 2025 still relied mostly on the first full consolidation year of the acquisition, so 2026 needs to prove the platform can keep growing organically while holding margin.
Amal generated strong operating cash in 2025, but once reported capex, capitalized development, interest, lease principal, dividends, and debt repayments are included, flexibility nearly disappeared and the group needed debt rollover to preserve a cash cushion.
The National Insurance tender is a real threat to Amal’s core engine, but mainly through the unit economics and profitability of home care rather than through an immediate loss of the activity itself.